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Background 
Tuberculosis (TB) remains the leading cause of death 
due to an infectious disease among adults worldwide. 
Currently, tuberculosis causes more than 10 million 
cases globally, resulting in approximately 1.5 million 
deaths each year [1]. The global distribution of the dis-
ease is widely heterogeneous. The lowest rates are most-
ly registered in high-income countries, including most 
Western European countries, Canada, the United States 
of America, Australia and New Zealand. 
The epidemiology of TB in low-incidence countries 
(<  10 cases per 100,000 inhabitants per year) is char-
acterized by a low transmission rate in the population 
at large, and this has progressively declined over recent 
decades.
Europe’s TB burden is among the lowest in the world, 
and overall notifications in most countries have been de-
creasing over the last five years [2].
Many efforts have been made in recent years to eradi-
cate TB, particularly through the detection and active 
management of TB cases. This strategy alone, however, 
is not enough to eliminate TB. In order to successfully 
break the chain of infection and disease, an integrated 
strategy  [3,  4] that includes LTBI management is re-
quired. 
In addition, it is estimated that approximately 1.7 billion 
people globally (a fourth of the world’s population) are 
infected with Mycobacterium tuberculosis (MT) [5]. 
In this regard, as most new TB cases are the result of re-
activation of LTBI rather than a recent primary infection, 
the enhancement of LTBI screening and treatment strate-
gies is well recognized as a key driver of TB elimination, 
especially in areas of low TB prevalence. 
The incidence of active cases is concentrated among 
vulnerable groups, hard-to-reach populations and cross-
border migrants. One of the most complex challenges in 
this area is to identify population subgroups with a high 
incidence/prevalence of TB. Today, prioritized strategies 
in low-incidence countries must therefore be geared to-
wards targeted interventions in these populations, with 
the aim of identifying and treating infections promptly 
rather than managing cases of TB disease. 
It is well known that the transmission of MT is more 
likely in confined environments where population den-
sity is high, such as healthcare facilities, shelters for the 
homeless, long-term care facilities, and community set-
tings such as schools and workplaces. The concentration 
of active TB cases in congregate settings engenders a 
greater risk of transmission of MT among those who fre-
quent these settings. The presence of vulnerable popu-
lations in high congregate settings might constitute one 
of the worst scenarios, especially in non-healthcare set-
tings. As defined by the CDC, a congregate setting is an 
environment where a number of people reside, meet or 
gather in close proximity for either a limited or extended 
period of time [6]. The aim of the present study was to 
provide an overview of the literature on the epidemiol-
Countries where the incidence of Tuberculosis (TB) is low display 
a low transmission rate in the general population, and this rate 
has progressively declined in recent decades; however, TB epide-
miology has shown a shift of the disease burden from the general 
population to specific populations at higher risk, such as vul-
nerable individuals and hard-to-reach groups. In low-incidence 
countries, preventive and therapeutic strategies must therefore be 
geared towards targeted interventions in these populations, with 
the priority being to promptly identify and treat latent tuberculosis 
infection (LTBI) rather than manage infectious cases. One of the 
most complex challenges in this area is to identify population sub-
groups with increased incidence/prevalence of LTBI/TB. 
The aim of this study was to provide a concise overview of the 
main studies and available evidence concerning the epidemiol-
ogy of TB and LTBI in non-healthcare congregate settings, with 
specific emphasis on studies conducted in occupational settings 
and workplaces. 
Recognizing settings at increased risk might contribute to elimi-
nating TB in low-incidence countries, a challenge which requires 
tailored responses. 
Occupational and preventive medicine has a major role to play 
in directing ad hoc policies and programs of LTBI surveillance. 
If TB is to be eradicated, it is essential to contain the seedbeds of 
infection: indeed, as long as a large reservoir of infected subjects 
exists, new active TB cases may arise at any time.
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ogy of TB and LTBI in non-healthcare congregate set-
tings, with specific emphasis on studies conducted in oc-
cupational settings or studies comparing the prevalence/
incidence rates of LTBI/TB in such settings with those 
recorded in the general population. 
Methods
An analysis of the literature by means of a method that 
simplifies the components of a systematic search  [7] 
formed the basis of the rapid overview of evidence pre-
sented in this study. Medline and Embase electronic 
databases were searched for articles published between 
January 2000 and December 2019 that reported epide-
miological data on TB/LTBI in congregate settings. The 
search was restricted to countries and territories with a 
low incidence of TB, as per the latest WHO data  [1], 
and to systematic reviews and meta-analyses of obser-
vational studies. The language was restricted to English 
and Italian. Our search contained the following terms: 
tuberculosis, LTBI, prison, congregate and occupational 
setting (tuberculosis OR TB OR latent tuberculosis in-
fection OR LTBI) AND ((congregate OR highly popu-
lated) OR (prisons OR correctional OR shelters)) OR 
(workplace OR occupational). Approval from the Ethics 
Committee was not required. 
Results
A total of 5,934 citations were screened. Subsequently, 
15 articles [8-22] fulfilled the eligibility criteria and 
were included (Fig. 1). 
Summary of studies included
A briefly summary of the studies included is reported in 
Table I.
Fig. 1. PRISMA 2009 flow chart of the literature search.
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Baussano and colleagues [8] conducted a systematic re-
view to investigate the incidence and risk of LTBI and 
TB in prisons in various countries in comparison with 
the general population. The review included 23 original 
studies from the 1990s to 2010. Five studies from the 
US and one from Brazil assessed the incidence of LTBI 
in penitentiaries; n = 19 investigated the incidence of TB 
(n = 13 in low-incidence settings); n = 2 studies investi-
gated both the impact of infection and the disease. The 
estimated average annual incidence rate ratio (IRR) for 
LTBI was 26.4 (interquartile range [IQR]: 13.0-61.8); 
the IRR for TB was 23.0 (IQR: 11.7-36.1). The estimat-
ed median fraction (PAF%) of TB in the general popula-
tion attributable to exposure in prison settings was 8.5% 
(IQR: 1.9% -17.9%) and 6.3% (IQR: 2.7% -17.2%) in 
low-/middle-income countries.
Kawatsu and colleagues [9] carried out a systematic re-
view to investigate the incidence of LTBI among prison 


















NA 3,47 (95% CI: 
1.78-5.73; I2 
= 94.9%; p 
<0.0001) every 
1,000
Country of origin, 
post-migration 
factors such 
as duration of stay in 
host country
Establish factors during 
migration and initial 
accommodation which may lead 
to higher transmission rates or 
re-activation of LTBI







NA Prevalence of 
positivity to 
the TST varied 
between 30 
and50%, of 
these, IGRA test 
positivity ranged 








birth, poor living 
conditions, poor 
nutrition













36 to 47 every 
100,000
Difficulties regarding 
access to medical 
care, duration of 
contagiousness, 
delayed diagnosis
Identification and treatment of 






NA NA NA Belonging to an 
ethnic minority, 
being a native 
of the country, 
residing in an urban 





young age, male 
gender
Improvement of prevention and 
control strategies









ranged from 2.3 






associated with the 
incidence of con-
version
Improvement of TST screening 
and medical surveillance of 











ranged from 17% 
to 52% in Europe; 








Male gender, long 
periods of injected 
substance abuse, 
HIV-negative 
status and TCD4+ 
lymphocyte values 
within normal range
Improve surveillance of TB and 








ranged from 10% 
to 59%.
NA Age and duration 
of drug abuse, 
homelessness, 
alcohol abuse and 
history of detention
Prompt identification of LTBI, 




A. MONTECUCCO ET AL.
E328
inmates. They reported an LTBI incidence of 40.3% 
in countries with a low incidence of TB and 73.0% in 
countries with a medium/high incidence. The incidence 
of LTBI ranged from 5.9 to 6.3 per 100 inmates in coun-
tries with a low incidence of TB, while it was 61.8 per 
100 inmates in countries with a high incidence.
Moreira and colleagues  [10] conducted a systematic 
meta-analysis review that investigated the prevalence of 
TB among prison inmates between 1997 and 2016. Their 
study included n = 29 original articles regarding 2163 
cases of TB among inmates. The combined prevalence 
of TB among inmates was 2%. The prevalence among 
detainees from countries with a TB incidence between 0 
and 24 cases per 100,000 inhabitants was less than 1%. 
In countries with a TB prevalence of 25-99/100,000, the 
prevalence of TB among prisoners was reported to be 
3%; in countries with an incidence ≥ 300/100,000 inhab-
itant, the prevalence was reported to be 8%.
A study conducted in the USA by Lambert et al.  [11] 
found 299 cases of active TB among prison employees 
in 35 US states; 49% of the diagnoses were made at the 
onset of clinical symptoms, 31% of the diagnoses were 
incidental, 11% were made through occupational health 
surveillance, and 9% were made through contact investi-
gations of contagious cases. 
The study by Binswanger et al.  [12] was conducted in 
the USA on a population of 81,610 prison employees. 
Of the correctional facilities included in the study, 5.5% 
reported at least one episode of cuti-conversion to TST 
among employees. 
The systematic meta-analysis review by Grenzel et 
al.  [13] reported a prevalence of LTBI among prison 
workers in low-incidence countries of 16% ([95% CI 
10-22%], I2 = 93.3%, p < 0.001). The incidence of ac-
tive TB in low-burden countries ranged from 0.61 to 450 
every 10,000.
Reception centres for asylum seekers
Kunst and colleagues  [14] conducted a systematic re-
view of 46 studies to investigate the prevalence of LTBI 
and TB among migrants in the European context. The 
median yield of reported cases at the reception centres 
was 431 cases per 100,000 assessed. N = 20 studies that 
investigated screening for LTBI were included. Positiv-
ity (≥ 10 mm of intradermal hardening) to TST (inter-
quartile range) ranged between 27.8% and 44.9%, while 
Interferon Gamma Release Assay test (IGRA) positivity 
was found to be between 17.4% and 29%.
Lönnroth and colleagues [15] conducted a systematic re-
view to investigate the prevalence of TB among migrants 
in low-incidence countries. The authors reported that the 
absolute number of TB notifications in subjects born 
abroad increased in 14 of the 30 low-incidence countries 
in the period 2009-2015. They found that asylum seekers 
and refugees were at increased risk of TB, owing to the 
difficulties faced during migration, overcrowded condi-
tions in both the countries of origin and destination, and 
factors such as malnutrition, exposure to infectious cases 
and a higher incidence of HIV in these individuals.
Bozorgmehr and colleagues [16] investigated the screen-
ing data on asylum seekers in Germany from 1995 to 
2015 through a systematic meta-analysis. They reported 
that the prevalence of TB among asylum seekers was 
between 0.72 (95% CI: 0.45-1.10) and 6.41 (95% CI: 
4.19-9.37) per 1,000 subjects. The aggregate estimated 
prevalence of active TB cases in the studies included was 
3.47 (95% CI: 1.78-5.73; I2 = 94.9%; p < 0.0001) per 
1,000 asylum seekers.
In 2017, Scotto and colleagues [17] conducted a study 
on the incidence of TB among migrants in Italy in the 
period between 2000 and 2016. They reported that, in 
2014, 66% of new cases of TB were recorded in the mi-
grant population.
Homeless shelters
Bamrah and colleagues [18] conducted a study to ana-
lyse cases of active TB reported in the United States be-
tween 1994 and 2010. Overall, 270,948 active TB cases 
were reported in this time window, 16,527 (16.4%) of 
which occurred among homeless people.
A systematic review by Nava-Aguilera and col-
leagues  [19] revealed that recent transmission of TB 
was concentrated in some vulnerable population groups, 
including: ethnic minorities (OR 3.03, 95% CI: 2.21-
4.16); urban residents (OR 1.52, 95% CI: 1.35-1.72); 
drug abusers (OR 3.01, 95% CI: 2.14-4.22); alcohol 
abusers (OR 2.27, 95% CI 1.69-3.06); homeless persons 
(OR 2.87, 95% CI: 2.04-4.02); former prison inmates 
(OR 2.21, 95% CI: 1.71-2.86); HIV-infected subjects 
(OR 1.66, 95% CI: 1.36-2.05); and the young (OR 2.09, 
95% CI: 1.69-2.59).
Isler and colleagues  [20] investigated the results of an 
LTBI screening program for employees of homeless 
shelters in the Montreal metropolitan area between 1998 
and 2005. Both subjects who were cuti-positive (10 mm 
cut-off) at the start of the study and cuti-converted sub-
jects (10 mm cut-off) were included. The prevalence of 
subjects with TST positivity at the start of the study was 
12.9%. The incidence of cuti-conversion ranged from 
2.3/100 person-years to 3.5/100 person-years. The in-
cidence of cuti-conversion was not significantly associ-
ated with demographic or occupational items such as the 
type of employment.
Drug rehabilitation communities
A review by Grenfell and colleagues  [21] investigated 
the prevalence of LTBI and TB in intravenous drug us-
ers. In studies conducted in Europe, the prevalence of 
LTBI ranged from 17% to 52%, with a higher incidence 
in prison settings. In North America, intravenous drug 
users had an LTBI prevalence between 12% and 39%. 
The prevalence of active TB ranged from 0.5% to 66%; 
this wide heterogeneity among studies was due to dif-
ferences in the methods of detection and definition of 
active TB. 
Deiss and colleagues [22] also conducted a review inves-
tigating the prevalence of LTBI and TB in intravenous 
drug users. They reported that this vulnerable popula-
tion was at increased risk of both LTBI and TB, with 
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an observed prevalence of LTBI between 10% and 59%. 
Prolonged intravenous drug abuse and age proved to be 
associated with a higher prevalence of LTBI.
Brief final remarks
The studies mentioned, which were performed in coun-
tries with a low incidence of TB, provide a brief sum-
mary of the epidemiology of LTBI and TB in congregate 
settings and workplaces.
Adequate knowledge of up-to-date epidemiological data 
is a crucial first step in the risk assessment of occupa-
tional settings and a useful means of identifying reser-
voirs of TB infection at the community level, thereby 
contributing to the mapping of risk factors and the iden-
tification of groups at risk. 
Furthermore, such environments (e.g. prisons), are fre-
quently characterized by poor hygiene conditions, poor 
ventilation and a high prevalence of subjects at higher 
risk of active TB (e.g., drug abusers, alcoholics, immi-
grants from high-incidence areas for TB, individuals 
with HIV/AIDS, individuals with reduced access to care 
services). A lack of Infection and Prevention Controls 
(IPC) (e.g., administrative and environmental controls) 
in these settings may help to explain the increased risk 
of transmission of MT.
The heterogeneity of work environments makes it more 
difficult to assess the risk of LTBI, which is influenced 
by age and demographic structure, cultural factors, pop-
ulation density and migration patterns. Environmental 
factors, such as overcrowding and poor ventilation, have 
a direct impact on air exchange from person to person, 
which increases the likelihood of transmission.
Recognizing risk factors and settings at increased risk 
might contribute to eliminating tuberculosis in low-in-
cidence countries, a challenge which requires tailored 
responses. As LTBI is most often a prerequisite for the 
development of TB in immunocompetent individuals, it 
appears essential to identify, as early as possible, those 
who have been infected after proven or suspected expo-
sure to a case of contagious TB (pulmonary or laryn-
geal), in order to properly assess the risk of developing 
active TB and to implement preventive measures. Con-
tainment of the seedbeds of TB is essential in order to 
reach the goal of eliminating the disease: indeed, as long 
as a large reservoir of infected subjects remains, new ac-
tive TB cases may arise at any time. Given the estimated 
prevalence of LTBI and the current shortage of tests and 
treatments, a further major effort is required. This effort 
should include: a surveillance system, scaling up tar-
geted testing for LTBI in populations at risk, expanding 
short-term treatment regimens, involving both affected 
communities and medical service providers, and increas-
ing the healthcare personnel involved in implementation 
and supervision. Such efforts would greatly benefit from 
the development of new tools, such as tests that more ac-
curately assess the risk of reactivation as well as shorter 
LTBI treatment [23, 24]. 
In order to direct these efforts and make targeted choic-
es, an essential first step is to identify subjects with the 
highest risk of exposure, who should be targeted for LT-
BI testing; occupational medicine could play a key role 
in this activity. Strategies for risk assessment are based 
on: (I) the workplace environment (e.g. local epidemio-
logical and environmental features); (II) specific care 
activities performed; (III) risk factors for the increased 
likelihood of progression from LTBI to active disease. 
These key principles stress the role of occupational 
and preventive medicine in directing tailored policies 
for LTBI surveillance. Moreover, Occupational Health 
Surveillance programs, in close collaboration with the 
Departments of Prevention of the Local Health Authori-
ties, could aim to reduce losses at steps of LTBI cas-
cade of care, thereby enhancing the public health impact 
of proper diagnosis and treatment and contributing to 
achieving major results in terms of Public health.
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